San Diego, CA, United States
San Diego, CA, United States

Time filter

Source Type

To provide an overview of molecular and cellular processes involved in erectile dysfunction (ED) with emphasis on circulating endothelial progenitor cells (EPC) and discuss possible nutraceutical means of intervention. A review of literature on Pubmed related to EPC and ED was conducted. Patients with ED appear to possess a reduced number of circulating EPC, which is associated with poor endothelial function possibly as a result of underlying low-grade inflammation. Several studies support the possibility of improving erectile function by inhibition of inflammation as well as administration of various stem cell types. One particularly interesting approach is nutraceutical supplementation to increase circulating EPC, as demonstrated in the product Stem-Kine. Interventions aimed at increasing circulating EPC may have potential in treatment of vascular ED.


Dasanu C.A.,Saint Francis Hospital and Medical Center | Ichim T.E.,MediStem Inc. | Alexandrescu D.T.,Regen BioPharma Inc.
Journal of Oncology Pharmacy Practice | Year: 2013

Transverse leukonychia (Leukonychia striata or Muehrcke's lines) has been described with the use of several drugs in oncology, mainly chemotherapeutic agents. This condition is thought to represent an abnormality of the vascular nail bed. As the diagnosis is clinical and the condition is self-limited, referral to other specialists is usually not required. We report the first case of transverse leukonychia related to the use of transretinoic acid for acute promyelocytic leukemia. Physician awareness of transverse leukonychia is important in order to reassure the patients and avoid unnecessary (and often not inexpensive) diagnostic work-up. © 2013 The Author(s).


Disclosed are stem cells and nanoparticles derived from said stem cells, useful for the treatment of acute radiation syndrome (ARS) and other inflammatory conditions. In one embodiment, Endometrial Regenerative Cells (ERC) are administered to patients having been exposed to radiation to augment recovery of endogenous hematopoietic stem cells. In another embodiment, exosomes, nanoparticles that are generated by various stem cells are used as a drug for treatment of inflammatory conditions.


The use of endometrial regenerative cells (ERC) and other endometrial originating cells for the treatment of traumatic brain injury is disclosed. In one embodiment a patient is administered a population of CD90 positive, CD105 positive, allogeneic regenerative cells subsequent to a brain injury. Cell concentration, frequency of administration, and route of administration may be determined based on extent of injury, inflammatory response and endogenous stem cell mobilization. In one embodiment, a patient suffering from traumatic brain injury is administered a dose of 100 million Endometrial Regenerative Cells intravenously at a rate of 1 million cells per minute in a volume of 100 ml of saline.


Patent
Medistem Inc. | Date: 2013-01-31

Disclosed are methods, compositions of matter, and protocols useful for the induction of a therapeutic immune modulatory response through administration of exosomes derived from a stem cell source. In one embodiment, said stem cell source is endometrial regenerative cells. Specifically, in one embodiment stem cell derived exosomes are used as a method of treating an autoimmune condition such as rheumatoid arthritis, multiple sclerosis, or systemic lupus erythromatosis.


Disclosed are methods of preparing and using placentally-derived stem cells and compositions useful for the treatment of cancer. Said stem cells and compositions function through inducing a guided differentiation program in cancer cells, thereby reducing malignancy. Further extension of the invention pertains to augmenting ability of administered cells to induce differentiation through the co-administration of known differentiation inducing agents. Within the context of this disclosure, methods for inducing host responses to cancer are also described.


News Article | November 8, 2016
Site: www.newsmaker.com.au

Global Stem Cell Banking Market is accounted for $1.42 billion in 2015 and is expected to reach $4.58 billion by 2022 growing at a CAGR of 18.2% during the forecast period. Growing number of newborns, increasing usage of stem cells in disorder treatment and rising disposable income are some of the factors fueling the market growth. However, huge operating price and regulatory changes are some of the factors hampering the market. Rising awareness about potential use of cord tissue and the automation of procedures are creating opportunities for vendors in the market. Some of the key players in Stem Cell Banking market include Cordvida, International Stem Cell Corporation, BrainStorm Cell Therapeutics, ReeLabs, Gamida Cell, Cryo Stemcell, Medistem Inc, CordCare, RMS Regrow, Cellular Dynamics International, Arteriocyte, ReNeuron Group, Jeevan Blood Bank Research Center, RhinoCyte, Inc., Cytori Therapeutics, Inc. and StemOne Biologicals. Regions Covered:  • North America  o US  o Canada  o Mexico  • Europe  o Germany  o France  o Italy  o UK  o Spain  o Rest of Europe  • Asia Pacific  o Japan  o China  o India  o Australia  o New Zealand  o Rest of Asia Pacific  • Rest of the World  o Middle East  o Brazil  o Argentina  o South Africa  o Egypt What our report offers:  - Market share assessments for the regional and country level segments  - Market share analysis of the top industry players  - Strategic recommendations for the new entrants  - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets  - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)  - Strategic recommendations in key business segments based on the market estimations  - Competitive landscaping mapping the key common trends  - Company profiling with detailed strategies, financials, and recent developments  - Supply chain trends mapping the latest technological advancements About Us Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.


News Article | November 8, 2016
Site: marketersmedia.com

— Global Stem Cell Banking Market is accounted for $1.42 billion in 2015 and is expected to reach $4.58 billion by 2022 growing at a CAGR of 18.2% during the forecast period. Growing number of newborns, increasing usage of stem cells in disorder treatment and rising disposable income are some of the factors fueling the market growth. However, huge operating price and regulatory changes are some of the factors hampering the market. Rising awareness about potential use of cord tissue and the automation of procedures are creating opportunities for vendors in the market. Some of the key players in Stem Cell Banking market include Cordvida, International Stem Cell Corporation, BrainStorm Cell Therapeutics, ReeLabs, Gamida Cell, Cryo Stemcell, Medistem Inc, CordCare, RMS Regrow, Cellular Dynamics International, Arteriocyte, ReNeuron Group, Jeevan Blood Bank Research Center, RhinoCyte, Inc., Cytori Therapeutics, Inc. and StemOne Biologicals. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Us Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. For more information, please visit https://www.wiseguyreports.com/reports/731622-stem-cell-banking-global-market-outlook-2016-2022


— Growing number of newborns, increasing usage of stem cells in disorder treatment and rising disposable income are some of the factors fueling the market growth. However, huge operating price and regulatory changes are some of the factors hampering the market. Rising awareness about potential use of cord tissue and the automation of procedures are creating opportunities for vendors in the market. Some of the key players in Stem Cell Banking market include Cordvida, International Stem Cell Corporation, BrainStorm Cell Therapeutics, ReeLabs, Gamida Cell, Cryo Stemcell, Medistem Inc, CordCare, RMS Regrow, Cellular Dynamics International, Arteriocyte, ReNeuron Group, Jeevan Blood Bank Research Center, RhinoCyte, Inc., Cytori Therapeutics, Inc. and StemOne Biologicals. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Stratistics MRC We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. For more information, please visit http://www.strategymrc.com/


News Article | November 23, 2016
Site: www.newsmaker.com.au

According to Stratistics MRC, the Global Stem Cell Banking Market is accounted for $1.42 billion in 2015 and is expected to reach $4.58 billion by 2022 growing at a CAGR of 18.2% during the forecast period. Growing number of newborns, increasing usage of stem cells in disorder treatment and rising disposable income are some of the factors fueling the market growth. However, huge operating price and regulatory changes are some of the factors hampering the market. Rising awareness about potential use of cord tissue and the automation of procedures are creating opportunities for vendors in the market. Some of the key players in Stem Cell Banking market include Cordvida, International Stem Cell Corporation, BrainStorm Cell Therapeutics, ReeLabs, Gamida Cell, Cryo Stemcell, Medistem Inc, CordCare, RMS Regrow, Cellular Dynamics International, Arteriocyte, ReNeuron Group, Jeevan Blood Bank Research Center, RhinoCyte, Inc., Cytori Therapeutics, Inc. and StemOne Biologicals. • Leukemia • Cerebral Palsy • Autism • Thalassemia • Diabetes • Other Applications Bank Types Covered: • Cord Tissue • Cord Blood  Service Types Covered: • Analysis • Collection & Transportation • Storage • Processing Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK  o Spain o Rest of Europe       • Asia Pacific o Japan        o China        o India        o Australia        o New Zealand       o Rest of Asia Pacific • Rest of the World o Middle East o Brazil       o Argentina        o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements

Loading Medistem Inc collaborators
Loading Medistem Inc collaborators